Elevance Health faces mix of hurdles
For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks. And 2025 holds more challenges but also an opportunity for a rebound.
Health Care & Life Sciences
-
Q&A: OrthoIndy’s John Ryan talks about staying independent in a consolidating health care industry
The economics are daunting: Rising costs and flat reimbursements mean private groups must work harder to stay independent.
Read More -
Why Lilly is pouring billions into LEAP
In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And modes of drug delivery are becoming increasingly complex.
Read More -
Blood specialists in demand as caseloads grow
In response, an Indianapolis medical practice is trying to train more early-career physicians in the field of hematology to reverse the trend of dwindling numbers of physicians entering the field.
Read More -
IEDC still looking for buyers for portion of GM stamping plant property
Economic development leaders want the 45 acres to be developed as the OneHealth Innovation District—a partnership between Elanco Animal Health, Purdue University and the Indiana Economic Development Corp.
Read More
Articles
Lebanon planning board OKs design for Lilly Medicine Foundry at LEAP District
The foundry will give the pharmaceutical maker the ability to research new ways of producing medicines.
Trump casts psychiatric and weight-loss drugs as threats to children
President Donald Trump has instructed his administration to scrutinize the “threat” to children posed by antidepressants, stimulants and other common psychiatric drugs.
What we know about avian flu spread in Indiana
Hoosier farmers are on edge as the bird flu—officially the highly pathogenic avian influenza, or HPAI—continues to menace big and small flocks alike three years into this outbreak.
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.’s Omvoh, a new therapy to treat Chron’s disease and ulcerative colitis, is the company’s latest step into the treatment of gastrointestinal diseases.
Cook Group president: New IU LAB vital for Indiana health care research
Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new Indiana University IU Launch Accelerator for Biosciences, or IU LAB.
Carmel company launches mental health app
Syra Health is looking to its new AI-powered app, Syrenity, to help it reach profitability and establish itself as a provider of high-tech mental health services.
Hancock Health leads development of 160-acre mixed-use campus
The health care company has expanded its reach over the past seven years to become a master developer for a sprawling project on the south side of Interstate 70 in western Hancock County.
New life sciences consortium aims to give Indiana researchers better access to health data
AnalytiXIN has launched a consortium designed to give Indiana researchers better access to health care data—potentially helping Eli Lilly and Co. and other companies develop new medicines more quickly.
Q&A with Kristin Sherman: Life sciences veteran is fighting for women’s health
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human papillomavirus infections before cancer develops and to treat HPV cancers after detection.
FDA approves Lilly’s Zepbound for obstructive sleep apnea
Lilly’s stock was up slightly in after-hours trading.
Lilly stock caught up in wave of uncertainty
After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ride since September.
GeniPhys builds momentum with wound care technology
After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its next big steps: regulatory approval and commercial launch.
Lilly CEO Dave Ricks named Watanabe Award winner
Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care innovation.
Years after fanfare, hospital remains unbuilt
But two years after the groundbreaking for an Ascension St. Vincent facility in West Lafayette, the planned $25 million development has little to show for itself. The 7-acre site sits empty, with no indication that anything is coming soon.
Insurer-provider contract impasses leave many patients without care
Indiana physicians are keeping an eye on the trend of large insurers dropping medical practices from their networks, which they call a classic case of David versus Goliath.
Carmel-based MBX Biosciences shares jump 48% in Nasdaq debut
The five-year-old company is developing treatments for endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity. Its positive reception on Wall Street was seen as an extension of the general enthusiasm for obesity treatments.
Lilly names new chief financial officer
Lucas Montarce, who has been with Lilly since 2001 and most recently served as president for its Spain, Portugal and Greece operations, is now the company’s CFO and executive vice president.
Fishers-based Flexware acquires North Carolina-based engineering services firm
Fishers-based Flexware Integration LLC, a fast-growing IT services provider, has acquired Castle Hill Technologies LLC, a North Carolina-based company that provides engineering services to the pharmaceutical industry.
Medical debt proposal draws mixed response
A national proposal to remove medical debt from consumer credit reports could have a significant impact in Indiana, where the percentage of residents with delinquent medical debt is higher than in 39 other states.